Literature DB >> 21263260

Screening and early detection of lung cancer.

Susan C Van't Westeinde1, Rob J van Klaveren.   

Abstract

Lung cancer with an estimated 342,000 deaths in 2008 (20% of total) is the most common cause of death from cancer, followed by colorectal cancer (12%), breast cancer (8%), and stomach cancer (7%) in Europe. In former smokers, the absolute lung cancer risk remains higher than in never-smokers; these data therefore call for effective secondary preventive measures for lung cancer in addition to smoking cessation programs. This review presents and discusses the most recent advances in the early detection and screening of lung cancer.An overview of randomized controlled computerized tomography-screening trials is given, and the role of bronchoscopy and new techniques is discussed. Finally, the approach of (noninvasive) biomarker testing in the blood, exhaled breath, sputum, and bronchoscopic specimen is reviewed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21263260     DOI: 10.1097/PPO.0b013e3182099319

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  17 in total

1.  High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis.

Authors:  Jorge Nieva; Marco Wendel; Madelyn S Luttgen; Dena Marrinucci; Lyudmila Bazhenova; Anand Kolatkar; Roger Santala; Brock Whittenberger; James Burke; Melissa Torrey; Kelly Bethel; Peter Kuhn
Journal:  Phys Biol       Date:  2012-02-03       Impact factor: 2.583

2.  MiR-15a-16 represses Cripto and inhibits NSCLC cell progression.

Authors:  Feng Chen; Shi-ke Hou; Hao-jun Fan; Ying-fu Liu
Journal:  Mol Cell Biochem       Date:  2014-02-06       Impact factor: 3.396

3.  Infrared spectroscopy and microscopy in cancer research and diagnosis.

Authors:  Giuseppe Bellisola; Claudio Sorio
Journal:  Am J Cancer Res       Date:  2011-11-22       Impact factor: 6.166

4.  Diagnostic work-up and surgery in participants of the Gdansk lung cancer screening programme: the incidence of surgery for non-malignant conditions.

Authors:  Witold Rzyman; Malgorzata Jelitto-Gorska; Robert Dziedzic; Iwona Biadacz; Janina Ksiazek; Piotr Chwirot; Tomasz Marjanski
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-09-05

5.  Applications of MicroRNAs in the Diagnosis and Prognosis of Lung Cancer.

Authors:  Jun Shen; Feng Jiang
Journal:  Expert Opin Med Diagn       Date:  2012-05

6.  Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.

Authors:  Ayumu Taguchi; Katerina Politi; Sharon J Pitteri; William W Lockwood; Vitor M Faça; Karen Kelly-Spratt; Chee-Hong Wong; Qing Zhang; Alice Chin; Kwon-Sik Park; Gary Goodman; Adi F Gazdar; Julien Sage; Daniela M Dinulescu; Raju Kucherlapati; Ronald A Depinho; Christopher J Kemp; Harold E Varmus; Samir M Hanash
Journal:  Cancer Cell       Date:  2011-09-13       Impact factor: 31.743

7.  IGDB.NSCLC: integrated genomic database of non-small cell lung cancer.

Authors:  Sen Kao; Cheng-Kai Shiau; De-Leung Gu; Chun-Ming Ho; Wen-Hui Su; Chian-Feng Chen; Chi-Hung Lin; Yuh-Shan Jou
Journal:  Nucleic Acids Res       Date:  2011-12-01       Impact factor: 16.971

8.  DNA methylation biomarkers offer improved diagnostic efficiency in lung cancer.

Authors:  Georgios Nikolaidis; Olaide Y Raji; Soultana Markopoulou; John R Gosney; Julie Bryan; Chris Warburton; Martin Walshaw; John Sheard; John K Field; Triantafillos Liloglou
Journal:  Cancer Res       Date:  2012-09-07       Impact factor: 12.701

9.  Principal component analysis based feature extraction approach to identify circulating microRNA biomarkers.

Authors:  Y-h Taguchi; Yoshiki Murakami
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

10.  Effects of two genes coding squamous cell carcinoma antigen on the diagnosis and treatment of cervical squamous cell carcinoma.

Authors:  Qi'nan Yin; Ying Wang; Chenchen Zheng; Yanjuan Liu; Zhuo Chen; Fuer Lu; Guangying Huang
Journal:  Pak J Med Sci       Date:  2014-03       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.